Amphastar Pharma (AMPH) Ticks Lower Following Cautious Report

September 23, 2016 3:34 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Amphastar Pharma (NASDAQ: AMPH) ticked lower Friday following a cautious report at theStreet that suggested the cost of Naloxone could be the subject in the next drug price scandal.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Rumors, Trader Talk

Add Your Comment